Td Waterhouse Canada Inc. Theratechnologies Inc. Transaction History

Td Waterhouse Canada Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$0.55 - $2.89 $660,861 - $3.47 Million	-1,201,567 Closed	0 $0
Q2 2023 Nov 13, 2023	SELL	$0.78 - $1.01 $3,401 - $4,404	-4,361 Reduced 0.36%	1,201,567 $1.28 Billion
Q1 2023 Nov 13, 2023	SELL	$0.72 - $1.12 $3,507 - $5,455	-4,871 Reduced 0.4%	1,205,928 $1.32 Billion
Q4 2022 Nov 13, 2023	SELL	$0.83 - $8.04 $21,526 - $208,525	-25,936 Reduced 2.1%	1,210,799 $1.55 Billion
Q3 2022 Nov 13, 2023	SELL	$1.98 - $2.42 $63,375 - $77,459	-32,008 Reduced 2.52%	1,236,735 $3.68 Billion
Q2 2022 Nov 13, 2023	SELL	$2.21 - $2.7 $36,387 - $44,455	-16,465 Reduced 1.28%	1,268,743 $3.38 Billion
Q1 2022 Nov 13, 2023	SELL	$2.37 - $3.24 $7,467 - $10,209	-3,151 Reduced 0.24%	1,285,208 $3.92 Billion
Q4 2021 Nov 13, 2023	BUY	$2.92 - $3.76 $3.76 Million - $4.84 Million	1,288,359 New	1,288,359 $4.72 Billion

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $114M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Td Waterhouse Canada Inc., based on Form 13F filings with the SEC.

Stay updated on Td Waterhouse Canada Inc. with notifications on news.